|
|
|
Phibro Animal Health Corporation (NASDAQ: PAHC) |
|
|
|
| |
Phibro Animal Health Corporation Outlook |
On February 6 2025 the Phibro Animal Health Corporation provided following guidance
nnPhibro Animal Health Corporation Reports Second Quarter Results and Offers Revised Financial Outlooknn
TEANECK, N.J. – On February 6, 2025, Phibro Animal Health Corporation (Nasdaq: PAHC) revealed its financial performance for the second quarter concluded on December 31, 2024, along with a revised financial outlook for the fiscal year ending June 30, 2025. The company reported a robust increase in net sales and net income for the quarter when compared to the same period last year.
nnFinancial Highlights for the Quarter Ended December 31, 2024:nn
- nnNet Sales:nn Phibro achieved net sales of $309.3 million, which reflects a significant rise of $59.3 million or 24% compared to the $250 million recorded during the same quarter of the previous year.
- nnNet Income:nn The company reported a net income of $3.2 million, representing an increase of $1.9 million from the prior year, indicating a consistent upward trajectory in profitability.
Although Phibro has outlined its recent financial achievements and the positive trends observed in net sales and income, the specifics regarding the revised financial guidance for the fiscal year ending June 30, 2025, have not been detailed in the announcement. Stakeholders and s alike eagerly await more comprehensive insights into the company's projections for the upcoming fiscal year.
This performance underscores Phibro's strong market position and its strategic initiatives aimed at driving growth within the animal health sector. Further updates regarding more detailed financial guidance will likely be forthcoming, offering clearer expectations as the company navigates its future business landscape.,
|
On August 29 2024 the Phibro Animal Health Corporation provided following guidance
nnPhibro Animal Health Corporation Reports Fourth Quarter and Full Fiscal Year Results, Alongside Financial Guidance for Futurenn
TEANECK, N.J. – Phibro Animal Health Corporation (Nasdaq: PAHC), referred to as Phibro or he Company, has released its financial performance results for the fourth quarter and the entire fiscal year that concluded on June 30, 2024. The company also shared its financial outlook for the upcoming fiscal year ending June 30, 2025.
nnFourth Quarter Highlights – Three Months Ended June 30, 2024nn
- nnNet Salesnn: The Company reported net sales of $273.2 million for the fourth quarter. This represents an increase of $18.1 million, reflecting a growth rate of approximately 7% compared to the net sales figures from the same period the previous year, which were logged at $255.1 million.
- nnNet Incomenn: In terms of profitability, Phibro posted a net income of $0.8 million for the fourth quarter. This figure marks a decline of $10.7 million compared to last year’s net income of $11.5 million.
It is noteworthy that while the increase in net sales indicates robust revenue growth, the significant drop in net income suggests that the company faced challenges that affected its overall profitability during the quarter.
nnFull Fiscal Year Highlights – Year Ended June 30, 2024nn
While the details for the fiscal year results are not specified in this summary, the performance in the fourth quarter sets the stage for understanding the overall trajectory of the company’s financial health and operational effectiveness throughout the fiscal year.
nnFinancial Guidance for Fiscal Year 2025nn
Phibro Animal Health Corporation has provided its financial outlook for the fiscal year ending June 30, 2025. However, the exact figures or forecasts associated with this guidance are not detailed in the available information.
Overall, the results for the fourth quarter and the full fiscal year underline both the promising aspects of revenue growth as well as the challenges that the company must address moving forward. As financial guidance is anticipated, stakeholders will be monitoring the company closely to understand how these dynamics will play out in the next fiscal year.,
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
